House GOP healthcare plan would kill the medical device tax

capitol-hill-7x4A plan to repeal and replace the Affordable Care Act floated by Republicans yesterday – which critics have already dubbed “Trumpcare” or “Obamacare Lite” – would permanently repeal the medical device tax effective Jan. 1, 2018.

A hold on the 2.3% tax on U.S. medical device sales went into effect at the beginning of 2016 and is slated to expire by the end of this year. The legislative plan released last night by GOP members of the U.S. House of Representatives would kill the tax for good effective Jan. 1, 2018.

The House GOP plan would also immediately remove the penalty for people who do not have health insurance and halt the expansion of Medicaid at the beginning of 2020, capping funding for the federal healthcare program for the poor. It would preserve a pair of popular Obamacare features: Allowing children to remain on family health plans until age 26 and barring insurers from denying coverage for pre-existing conditions.

By Brad Perriello | MassDevice

Image Credit: MassDevice


About Peter Coffaro 439 Articles
A growth-driven and strategic executive, Peter Coffaro commands more than 20 years of progressive management success within the medical device industry. As a District Sales Manager for Stryker Orthopaedics, Peter was responsible for managing and directing a regional sales force to achieve sales and profit goals within the Rocky Mountain region. Previously, he was the Director of Sales & Marketing for Amp Orthopedics. In this role, Peter was responsible for planning, developing, and leading all sales and marketing initiatives. Peter is a former orthopedic distributor in the Pacific Northwest. He has also worked with DePuy Orthopaedics as well as Zimmer, and held positions in sales, sales training, and sales management. Peter has an extensive background in organizational development, business development, sales management, negotiating and P&L management. Peter holds a B.S. degree in Biology from Northern Illinois University.

Be the first to comment

Leave a Reply

Your email address will not be published.